These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22157717)

  • 1. CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133- cells.
    Chao C; Carmical JR; Ives KL; Wood TG; Aronson JF; Gomez GA; Djukom CD; Hellmich MR
    Lab Invest; 2012 Mar; 92(3):420-36. PubMed ID: 22157717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node stromal cells enhance drug-resistant colon cancer cell tumor formation through SDF-1α/CXCR4 paracrine signaling.
    Margolin DA; Silinsky J; Grimes C; Spencer N; Aycock M; Green H; Cordova J; Davis NK; Driscoll T; Li L
    Neoplasia; 2011 Sep; 13(9):874-86. PubMed ID: 21969820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.
    Rutella S; Bonanno G; Procoli A; Mariotti A; Corallo M; Prisco MG; Eramo A; Napoletano C; Gallo D; Perillo A; Nuti M; Pierelli L; Testa U; Scambia G; Ferrandina G
    Clin Cancer Res; 2009 Jul; 15(13):4299-311. PubMed ID: 19509143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDF-1α secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7.
    Bakondi B; Shimada IS; Peterson BM; Spees JL
    Stem Cells Dev; 2011 Jun; 20(6):1021-9. PubMed ID: 20854168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
    Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
    J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+CD44+ population efficiently enriches colon cancer initiating cells.
    Haraguchi N; Ohkuma M; Sakashita H; Matsuzaki S; Tanaka F; Mimori K; Kamohara Y; Inoue H; Mori M
    Ann Surg Oncol; 2008 Oct; 15(10):2927-33. PubMed ID: 18663533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD 133+ and CXCR4+ colon cancer cells as a marker for lymph node metastasis.
    Silinsky J; Grimes C; Driscoll T; Green H; Cordova J; Davis NK; Li L; Margolin DA
    J Surg Res; 2013 Nov; 185(1):113-8. PubMed ID: 23777983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker.
    Schneider M; Huber J; Hadaschik B; Siegers GM; Fiebig HH; Schüler J
    BMC Cancer; 2012 Mar; 12():96. PubMed ID: 22433494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model.
    Margolin DA; Myers T; Zhang X; Bertoni DM; Reuter BA; Obokhare I; Borgovan T; Grimes C; Green H; Driscoll T; Lee CG; Davis NK; Li L
    FASEB J; 2015 Aug; 29(8):3571-81. PubMed ID: 25962655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.
    Tirino V; Camerlingo R; Franco R; Malanga D; La Rocca A; Viglietto G; Rocco G; Pirozzi G
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):446-53. PubMed ID: 19464919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and metastatic potential of tumor-initiating cells in malignant rhabdoid tumor of the kidney.
    Yanagisawa S; Kadouchi I; Yokomori K; Hirose M; Hakozaki M; Hojo H; Maeda K; Kobayashi E; Murakami T
    Clin Cancer Res; 2009 May; 15(9):3014-22. PubMed ID: 19383826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CXCR4 and CD133 co-expression on the prognosis of patients with stage II~III colon cancer.
    Li XF; Guo XG; Yang YY; Liu AY
    Asian Pac J Cancer Prev; 2015; 16(3):1073-6. PubMed ID: 25735334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing migratory properties of human CD133(+) stem cells in vivo after intraoperative sternal bone marrow isolation.
    Donndorf P; Useini D; Lux CA; Vollmar B; Delyagina E; Laupheimer M; Kaminski A; Steinhoff G
    Cell Transplant; 2013; 22(9):1627-35. PubMed ID: 23051098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and expansion of human colon-cancer-initiating cells.
    Ricci-Vitiani L; Lombardi DG; Pilozzi E; Biffoni M; Todaro M; Peschle C; De Maria R
    Nature; 2007 Jan; 445(7123):111-5. PubMed ID: 17122771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.
    Lehwald N; Duhme C; Wildner M; Kuhn S; Fürst G; Forbes SJ; Jonas S; Robson SC; Knoefel WT; Schmelzle M; Schulte Am Esch J
    Liver Int; 2014 Jan; 34(1):89-101. PubMed ID: 23701640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.